Examples of Antengene Territory in a sentence
Once Karyopharm has finalized and validated the applicable manufacturing processes (both API and drug product) for each of Verdinexor, Eltanexor and, KPT-9274, Karyopharm shall promptly notify Antengene and, at any time thereafter, Antengene may elect to Manufacture such Licensed Compound and/or Licensed Product for Development and Commercialization purposes in the Field in the Antengene Territory.
Antengene shall have the right to authorize the protocol for each Investigator Sponsored Clinical Study in the Antengene Territory and support such Investigator Sponsored Clinical Study at Antengene’s own discretion, provided, however, Antengene agrees to inform Karyopharm of all such Investigator Sponsored Clinical Study(ies) in a timely manner and each proposal shall be subject to review and comment by a Working Group designated by the JOC.
Antengene shall have the first right to initiate an infringement or other appropriate suit or action in the Antengene Territory against any Third Party with respect to any Competitive Infringement in the Antengene Territory of any Antengene Technology with respect to a product competing with a Licensed Product in the Antengene Territory.
Antengene shall be responsible for bearing all costs and expenses incurred for patients enrolled in such Global Clinical Study in the Antengene Territory, provided that Antengene agrees to participate the Global Clinical Study.
Karyopharm shall have the first right to initiate an infringement or other appropriate suit or action in the Antengene Territory against any Third Party with respect to any Competitive Infringement in the Antengene Territory of any Karyopharm Technology with respect to a product competing with a Licensed Product in the Antengene Territory.
Antengene shall provide Karyopharm with written notice of each First Commercial Sale of a Licensed Product in a country in the Antengene Territory within [**] after such event; provided, however, that in all circumstances, Antengene shall inform Karyopharm of such event prior to public disclosure of such event by Antengene.
In no event shall Karyopharm be obligated to supply quantities of Licensed Compounds and/or Licensed Products in excess of amounts reasonably necessary to satisfy Antengene’s and its Related Party’s Development requirements in the Field in the Antengene Territory.
Antengene may register, in its discretion and at its expense, the licenses granted to Antengene under this Agreement with the Chinese Patent Office or any other appropriate Governmental Authority in any country of the Antengene Territory; provided that the Parties agree that such registration is not intended to affect the allocation of prosecution and enforcement rights and obligations set forth in Article 12.
If Antengene determines not to continue the Development of any one of Selinexor and Eltanexor in the Field in the Antengene Territory, Karyopharm shall provide the JOC with all Know-How on all then-existing candidates for Back-Up Compounds Controlled by Karyopharm or its Affiliates as soon as practicable after its receipt through JOC of such notification by Antengene.
With respect to each Licensed Compound, Antengene shall use Commercially Reasonable Efforts to Commercialize the Licensed Products in the Field in each country within the Antengene Territory (including obtaining all required pricing and reimbursement approvals) as promptly as possible following receipt by Antengene or its Related Parties of Regulatory Approval for such Licensed Product in such country.